Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000203772

Medchemexpress LLC PSMA-Val-Cit-PAB-MMAE | 2748039-79-2 | 99.5% | 2267.10 | C114H165ClN20O26 | 1 MG
SDP

Supplier:  Medchemexpress LLC HY1418601MG

Encompass_Preferred

PSMA-Val-Cit-PAB-MMAE is a small-molecule PSMA-targeted conjugate that uses a valine-citrulline (Val-Cit) peptide linker and a para-aminobenzyl (PAB) spacer to release the cytotoxic payload monomethyl auristatin E (MMAE) for research into PSMA-targeted chemotherapy of prostate cancer.

  • Small-molecule PSMA-targeted conjugate based on monomethyl auristatin E.
  • High purity (99.52%) and defined molecular formula and weight.
  • White to off-white solid appearance for ease of handling.
  • Storage: powder stable at -20°C for 3 years; in solvent stability at -80°C for 6 months.
  • Intended for research use only.

Catalog No. 50-002-03772


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.